Abstract: A dividing wall column is described which includes the following segments: a) an upper column region (1), b) an enrichment section (2) of the feed section, c) a stripping section (4) of the feed section, d) an upper part (3) of the offtake section, e) a lower part (5) of the offtake section, f) an intermediate region (9) of the feed section, g) an intermediate region (10) of the offtake section and h) a lower column region (6). The dividing wall column has a dividing wall (7) is located vertically between the segments b) (2) and d) (3) and between the segments c) (4) and e) (5). The segments b) (2), d) (3), c) (4) and e) (5) have separation-active internals, Segment b (2) has a cross-sectional area Ab which is at least 10% smaller than the cross-sectional area Ad of segment d) (3), and segment c) has a cross-sectional area Ac which is at least 10% greater than the cross-sectional area Ae of segment e) (5).

Abstract: A dividing wall column comprises the following segments: a) an upper column region (1), b) an enrichment section (2) of the feed section, c) a stripping section (4) of the feed section, d) an upper part (3) of the offtake section, e) a lower part (5) of the offtake section, f) an intermediate region (9) of the feed section, g) an intermediate region (10) of the offtake section and h) a lower column region (6). For the purposes of the present invention, it is essential that the dividing wall (7) is located vertically between the segments b) (2) and d) (3) and between the segments c) (4) and e) (5), the segments b) (2), d) (3), c) (4) and e) (5) have separation-active internals and the cross-sectional area Ab of the segment b) (2) is at least 10% smaller than the cross-sectional area Ad of segment d) (3), and the cross-sectional area Ac of the segment c) (4) is at least 10% greater than the cross-sectional area Ae of segment e) (5).

Abstract: Transport molecules include a dendrimer and a biologically active molecule. The dendrimer of such transport molecules includes at least one guanidine group, at least one protonated guanidine group, at least one protected guanidine group, at least one amidine group, at least one protonated amidine group, at least one protected amidine group, at least one ureido group, at least one protonated ureido group, at least one protected ureido group, at least one thioureido group, at least one protonated thioureido group, or at least one protected thioureido group. The biologically active molecule is bonded to the dendrimer. A method of increasing the bioavailability of a drug includes bonding the drug to a dendrimer of the invention.

Abstract: Transport molecules include a dendrimer and a biologically active molecule. The dendrimer of such transport molecules includes at least one guanidine group, at least one protonated guanidine group, at least one protected guanidine group, at least one amidine group, at least one protonated amidine group, at least one protected amidine group, at least one ureido group, at least one protonated ureido group, at least one protected ureido group, at least one thioureido group, at least one protonated thioureido group, or at least one protected thioureido group. The biologically active molecule is bonded to the dendrimer. A method of increasing the bioavailability of a drug includes bonding the drug to a dendrimer of the invention.

Abstract: The invention relates to a process for preparing constant-weight thrombin inhibitors of the formula I where n is 0, 1, 2, and tautomers thereof, wherein an aqueous solution of the active substance is spray dried.

Abstract: A process for preparing tocopheryl esters or tocotrienyl esters by acid-catalyzed esterification of a tocopherol or a tocotrienol in a solvent while stirring at elevated temperature, which comprises a) carrying out the esterification with the appropriate carboxylic acid, b) carrying out the esterification with from 2.5 to 6 mol of the carboxylic acid in an aliphatic, cycloaliphatic or aromatic hydrocarbon boiling in the range from 80 to 200° C., or else with from 1.0 to 2.5 mol of the carboxylic acid in a mixture consisting of an aliphatic or cycloaliphatic hydrocarbon boiling in the range from 80 to 200° C.